Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Louisiana Medical Policy Updates – December 2018
December 2018 BCBS Louisiana Medical Policy Updates:
- Ablation Procedures for Peripheral Neuromas
- Acoustic Cardiography-Archived Policy
- Aimovig (erenumab-aooe)
- Alternative Treatments of Benign Prostatic Hypertrophy – Archived Policy
- anakinra (Kineret)
- Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
- Autonomic Nervous System Testing
- avatrombopag (Doptelet )
- Bisphosphonates (Oral)
- Bone Growth Stimulation
- Bone Mineral Density Studies – Archived Policy
- Breast Duct Endoscopy – Archived Policy
- Bronchial Valves
- C1 Esterase Inhibitor (Berinert)
- C1 esterase inhibitor [recombinant] (Ruconest)
- Cardiopulmonary Exercise Stress Test (CPET) – Archived Policy
- Catheter Ablation as Treatment for Atrial Fibrillation
- cholic acid capsules (Cholbam)
- Cialis (tadalafil)
- Closure Devices for Patent Foramen Ovale and Atrial Septal Defects
- Combined Androgen Blockade for the Treatment of Metastatic Prostate Cancer – Archived Policy
- Conjunctival Incision with Posterior Juxtascleral Placement of Anecortave Acetate Depot Suspension – Archived Policy
- Corneal Collagen Cross-linking
- Coronary Computed Tomography Angiography With Selective Noninvasive Fractional Flow Reserve
- Cytochrome p450 Genotyping
- Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)
- Diabetic Test Strips
- Donor Leukocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Cell Transplant- Archived
- Drug Testing in Pain Management and Substance Abuse Treatment
- Dynamic Spinal Visualization
- emicizumab (Hemlibra)
- Endovascular Stent Grafts for Disorders of the Thoracic Aorta
- Epithelial Cell Cytology in Breast Cancer Risk Assessment and High-Risk Patient Management Ductal Lavage and Fiberoptic Ductoscopy – Archived Policy
- etanercept (Enbrel)
- Evzio (naloxone auto-injector)
- Facet Radiofrequency Denervation
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis- Archived Medical Policy
- Fecal Microbiota Transplantation
- Gait Analysis-Archived
- Gamma Interferon Blood Test for Diagnosis of Latent Tuberculosis – Archived Policy
- Gas Permeable Scleral Contact Lens Archived Medical Policy
- Gene Expression-Based Assays for Cancers of Unknown Primary
- Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Genetic Testing for Alzheimer’s Disease
- Genetic Testing for CHARGE Syndrome
- Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies
- Genetic Testing for Familial Cutaneous Malignant Melanoma
- Genetic Testing for Germline Mutations of the RET Proto-Oncogene in Medullary Carcinoma of the Thyroid – Archived Policy
- Genetic Testing for Hereditary Hemochromatosis
- Genetic Testing for Hereditary Pancreatitis
- Genetic Testing for Li-Fraumeni Syndrome
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Disorders
- Genetic Testing for Tamoxifen Treatment
- Gocovri (amantadine extended release)
- Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- Hematopoietic Cell Transplantation for Primary Amyloidosis or Waldenstrom’s Macroglobulinemia
- Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
- Hematopoietic Stem Cell Transplantation for Breast Cancer- Archived Policy
- Hematopoietic Stem-Cell Transplantation for Non-Hodgkin Lymphomas
- Hip Resurfacing
- Hippotherapy
- HIV Genotyping and Phenotyping- Archived Medical Policy
- HMG-CoA Reductase Inhibitors and HMG-CoA Reductase Inhibitor Combination Drugs
- Home Phototherapy for Neonatal Jaundice – Archived Policy
- Home Prothrombin Time Monitoring-Archived Policy
- Hysteroscopic Placement of Micro-inserts in the Fallopian Tubes as a Form of Permanent Sterilization – Archived Policy
- Identification of Microorganisms Using Nucleic Acid Probes
- Implantable Bone Conduction and Bone-Anchored Hearing Aids
- Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinus Disease
- In Vivo Colorectal Polyp Analysis – Archived Policy
- Injectable Bulking Agents for the Treatment of Urinary and Fecal incontinence
- Inpatient Intestinal Rehabilitation Therapy – Archived Policy
- Intra-arterial Brachytherapy for the Management and Treatment of Restenosis after Percutaneous Transluminal Angioplasty (PTA) – Archived Policy
- Intra-operative Neurophysiologic Monitoring (Sensory-evoked Potentials, Motor-evoked Potentials, EEG Monitoring) – Archived Policy
- Islet Transplantation
- itraconazole (Onmel)
- ivacaftor (Kalydeco)
- JAK2, MPL, and CALR Testing for Myeloproliferative Neoplasms
- Keratolimbal Allograft and Amniotic Membrane Transplant – Archived Policy
- Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
- Laser Treatment of Congenital Port Wine Stain Hemangiomas – Archived Policy
- Light Therapy for Psoriasis
- Local or Whole Body Hyperthermia – Archived Policy
- Lucemyra (lofexidine)
- lumacaftor/ivacaftor (Orkambi)
- Lung and Lobar Lung Transplant
- Lung Volume Reduction Surgery for Severe Emphysema – Archived Policy
- lusutrombopag (Mulpleta )
- Lymphedema Pumps – Archived Policy
- Magnetic Resonance Imaging Targeted Biopsy of the Prostate-Archived Medical Policy
- Magnetic Resonance-Guided Focused Ultrasound
- Metformin and Metformin Containing Products
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- mifepristone (Korlym)
- Miscellaneous Genetic and Molecular Diagnostic Tests
- Monitoring of Regional Cerebral Blood Flow Using an Implanted Cerebral Thermal Perfusion Probe – Archived Policy
- Naltrexone Implants/Pellets
- nesiritide (Natrecor) – Archived Policy
- nitisinone (Orfadin, Nityr)
- Nonmyeloablative Allogeneic Transplants of Hematopoietic Stem Cells for Treatment of Malignancy – Archived Policy
- Nutrient/Nutritional Panel Testing
- obeticholic acid (Ocaliva)
- Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus
- Opioid Antagonists Under Heavy Sedation or General Anesthesia as a Technique of Opioid Detoxification-Archived Medical Policy
- Opioid Management/Long Acting Oral Opioid Step Therapy
- Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy- Archived Policy
- Parenteral Therapy for Osteoporosis
- Partial Coherence Interferometry as a Technique to Measure the Axial Length of the Eye – Archived Policy
- pegvaliase-pqpz (Palynziq )
- Pegylated Interferons (Pegasys, PegIntron) for Other (Non-Hepatitis C) Uses- Archived Policy
- Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
- Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
- Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines
- Phosphate Binders
- Photodynamic Therapy for Choroidal Neovascularization
- Phototherapy Light for the Treatment of Seasonal Affective and Other Depressive Disorders – Archived Policy
- Placental and Umbilical Cord Blood as a Source of Stem Cells – Archived Policy
- Plasma Exchange (PE)
- Plasma Exchange (PE)
- Proton Beam Radiation Therapy
- Pulsed Irrigation of Fecal Impaction – Archived Policy
- Radioembolization for Primary and Metastatic Tumors of the Liver
- Radiofrequency Ablation of Primary or Metastatic Liver Tumors
- Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
- Radioimmunoscintigraphy Imaging (Monoclonal Antibody Imaging) With Indium-111 Capromab Pendetide for Prostate Cancer
- Scintimammography and Gamma Imaging of the Breast and Axilla
- Scoliosis Braces – Archived Policy
- Sensory Integration Therapy and Auditory Integration Therapy
- Serologic Diagnosis of Celiac Disease
- Serum Biomarker for Human Epididymis Protein 4 (HE4) – Archived Policy
- Siklos (hydroxyurea)
- sipuleucel-T (Provenge)
- Small Bowel Transplant, Small Bowel/Liver Transplant and Multivisceral Transplant
- Sympathetic Therapy for the Treatment of Pain – Archived Policy
- Systems Pathology in Prostate Cancer
- Thermography – Archived Policy
- Thoracic-Lumbo-Sacral Orthosis with Pneumatics- Archived Policy
- Tilt Table Testing – Archived Policy
- tocilizumab (Actemra)
- tolvaptan (Jynarque )
- Topical and Nasal Testosterone Products
- Topical Pain Patches
- Total Artificial Hearts and Implantable Ventricular Assist Devices
- Transciliary Fistulization for the Treatment of Glaucoma – Archived Policy
- Transcoronary Ablation of Septal Hypertrophy (TASH) – Archived Policy
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
- Transjugular Intrahepatic Portosystemic Shunt (TIPS) – Archived Policy
- Transpupillary Thermotherapy for Treatment of Choroidal Neovascular Conditions- Archived Policy
- Treatment of Hepatitis C with a simeprevir (Olysio) Based Regimen-Archived Medical Policy
- Treatment of Hepatitis C with a sofosbuvir (Sovaldi) Based Regimen
- Treatment of Hepatitis C with daclatasvir (Daklinza) plus sofosbuvir (Sovaldi)
- Treatment of Hepatitis C with elbasvir and grazoprevir (Zepatier)
- Treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)
- Treatment of Hepatitis C with ombitasvir, paritaprevir, and ritonavir (Technivie)
- Treatment of Hepatitis C with ombitasvir, paritaprevir, ritonavir, and dasabuvir (Viekira Pak/Viekira XR)
- Treatment of Hepatitis C with simeprevir (Olysio) PLUS sofosbuvir (Sovaldi) Archived Medical Policy
- Treatment of Hepatitis C with sofosbuvir/ledipasvir (Harvoni)
- Treatment of Hepatitis C with sofosbuvir/velpatasvir (Epclusa)
- Treatment of Hepatitis C with sofosbuvir/velpatasvir/voxilaprevir (Vosevi)
- Treatment of Hepatitis C with Triple Therapy (Ribavirin Plus Pegylated Interferon Alfa Plus telaprevir [Incivek] or boceprevir [Victrelis])- Archived Medical Policy
- Tumor-Treatment Fields Therapy for Glioblastoma-Retired Policy
- T-Wave Alternans- Archived Medical Policy
- Urinary Metabolite Tests for Adherence to Direct-Acting Antiviral Medications for Hepatitis C-Archived Medical Policy
- Urinary Tumor Markers for Bladder Cancer – Archived Policy
- Use of Common Genetic Variants (single nucleotide polymorphisms) to Predict Risk of Nonfamilial Breast Cancer
- Vacuum Therapy as a Treatment for Female Sexual Dysfunction – Archived Policy
- Vertebroplasty/Kyphoplasty
- Whole Gland Cryoablation of Prostate Cancer
Click here to view the Blue Cross Blue Shield Louisiana Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.